EBITDA of pharmaceutical company Recordati 2015-2022
The earnings before interests, taxes, depreciation, and amortization (EBITDA) of Italian pharmaceutical company Recordati increased steadily from 2015 to 2022. In the last year, the company reported an EBITDA of 672.8 million euros. Recordati is an international group headquartered in Milan, whose branches are operational all over the world.